NCT06698614View on ClinicalTrials.gov

MEMRI and Kidney Disease

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

November 7, 2024

Primary Completion Date

November 7, 2029

Study Completion Date

November 7, 2029

Conditions
Acute Kidney InjuryKidney TransplantVasculitisChronic Kidney Disease(CKD)
Interventions
DIAGNOSTIC_TEST

MRI

MRI imaging of the kidney and heart with an intravenous infusion of manganese dipyridoxl diphosphate (Mangafodipir, MnDPDP).

DIAGNOSTIC_TEST

Blood tests

full blood count, urea and electrolytes, liver function test, CRP, biomarkers for endothelial function, storage of serum and plasma for future analyses.

DIAGNOSTIC_TEST

Urine tests

Urine protein, Urine creatinine

DIAGNOSTIC_TEST

Cardiovascular analysis

24 hour blood pressure, arterial stiffness

Trial Locations (1)

Unknown

RECRUITING

NHS Lothian, Edinburgh

All Listed Sponsors
collaborator

NHS Lothian

OTHER_GOV

lead

University of Edinburgh

OTHER